To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Deposited Papers

Jul. 08 2020

Source Page: First do no harm: the report of the Independent Medicines and Medical Devices Safety Review, chaired by Baroness Cumberlege. Incl. appendices. 269p.
Document: First_Do_No_Harm_Report.pdf (PDF)

Found: First do no harm: the report of the Independent Medicines and Medical Devices Safety Review, chaired

Commons Chamber
Business of the House - Thu 02 Jul 2020
Leader of the House

Mentions:
1: Valerie Vaz (LAB - Walsall South) Those who have suffered from Primodos, sodium valproate and surgical mesh have campaigned for this. - Speech Link
2: Jacob Rees-Mogg (CON - North East Somerset) Lady when we were both elected in 2010 and had offices opposite each other, and she took up this issue - Speech Link
3: Cat Smith (LAB - Lancaster and Fleetwood) As chair of the all-party parliamentary group for valproate and other anti-epileptic drugs in pregnancy - Speech Link

Parliamentary Research
Expert Working Group report on hormone pregnancy tests - CDP-2019-0095
Apr. 18 2019

Found: Expert Working Group report on hormone pregnancy tests

Select Committee
Evidence given by Professor Dame Sally Davies, Chief Medical Officer for England, Alette Addison, Head of Pharmacy Development and Regulation, Department of Health and Social CareGenevieve Edwards, Director of External Affairs, MS Society, Professor Mike Barnes, Interim Chair, Medical Cannabis Clinicians' Society, Peter Carroll, Campaign Director, End Our PainProfessor Helen Cross, Head of Developmental Neurosciences, UCL GOS Institute of Child Health, Dr Imran Malik, Committee member, Royal College of Psychiatrists, Professor Sanjay Sisodiya, Chair of the ABN Epilepsy Advisory Group, Association of British Neurologists
 19 Mar 2019 - Drugs policy: medicinal cannabis - oral evidence

Oral Evidence Mar. 21 2019

Inquiry: Drugs policy: medicinal cannabis
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: 19 Mar 2019 - Drugs policy: medicinal cannabis - oral evidence Evidence given by Professor Dame Sally

Select Committee
Professor Dame Sally Davies, Chief Medical Officer for England, Alette Addison, Head of Pharmacy Development and Regulation, Department of Health and Social CareGenevieve Edwards, Director of External Affairs, MS Society, Professor Mike Barnes, Interim Chair, Medical Cannabis Clinicians' Society, Peter Carroll, Campaign Director, End Our PainProfessor Helen Cross, Head of Developmental Neurosciences, UCL GOS Institute of Child Health, Dr Imran Malik, Committee member, Royal College of Psychiatrists, Professor Sanjay Sisodiya, Chair of the ABN Epilepsy Advisory Group, Association of British Neurologists

Oral Evidence Mar. 19 2019

Inquiry: Drugs policy: medicinal cannabis inquiry
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: Dame Sally Davies, Chief Medical Officer for England, Alette Addison, Head of Pharmacy Development and

Parliamentary Research
Safety of Medicines and Medical Devices - LLN-2019-0024
Feb. 21 2019

Found: Safety of Medicines and Medical Devices

Non-Departmental Publication (Research and Statistics)
Public Health England (PHE)

Oct. 17 2018

Source Page: COMA reports
Document: COMA reports (PDF)

Found: One other hypothesis is that it might decrease the likelihood of an affected pregnancy surviving, and

Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 24 2018

Source Page: Valproate banned without the pregnancy prevention programme
Document: Valproate banned without the pregnancy prevention programme (webpage)

Found: Valproate banned without the pregnancy prevention programme

Lords Chamber
Medicines and Medical Devices Safety Review - Thu 22 Feb 2018
Department of Health and Social Care

Mentions:
1: Lord O'Shaughnessy (CON - Life peer) The second is sodium valproate, an effective anti-epilepsy drug which has been definitively linked to - Speech Link
2: Lord Hunt of Kings Heath (LAB - Life peer) Mesh has been suspended in Scotland and banned in other countries. - Speech Link
3: Baroness Masham of Ilton (CB - Life peer) My Lords, I thank the Minister for the support he has given to the epileptic women who have taken valproate - Speech Link

Commons Chamber
Valproate and Foetal Anticonvulsant Syndrome - Thu 19 Oct 2017
Department of Health and Social Care

Mentions:
1: Norman Lamb (LDEM - North Norfolk) and other anti-epileptic drugs in pregnancy, for facilitating this debate. - Speech Link
2: Norman Lamb (LDEM - North Norfolk) other anti-epileptic drugs in pregnancy, and for her campaigning. - Speech Link
3: Jim Shannon (DUP - Strangford) We must look beyond this debate and encapsulate what other people are saying.Sodium valproate is an anti-epileptic - Speech Link
4: Philippa Whitford (SNP - Central Ayrshire) We therefore must be careful not to send out a message that anti-epileptic drugs are bad, or even that - Speech Link
5: Philip Dunne (CON - Ludlow) , or any other anti-epileptic, without first discussing it with their doctor and, if necessary, with - Speech Link